Long-Term Administration of the Histone Deacetylase Inhibitor Vorinostat Attenuates Renal Injury in Experimental Diabetes through an Endothelial Nitric Oxide Synthase-Dependent Mechanism-Reference-Cited by-同舟云学术

Long-Term Administration of the Histone Deacetylase Inhibitor Vorinostat Attenuates Renal Injury in Experimental Diabetes through an Endothelial Nitric Oxide Synthase-Dependent Mechanism

Published:2011-05 Issue:5 Volume:178 Page:2205-2214
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Advani Andrew,Huang Qingling,Thai Kerri,Advani Suzanne L.,White Kathryn E.,Kelly Darren J.,Yuen Darren A.,Connelly Kim A.,Marsden Philip A.,Gilbert Richard E.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference47 articles.

1. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes;Nathan;N Engl J Med,2005

2. 10-Year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

3. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis;Rossig;Circ Res,2002

4. Diabetic eNOS knockout mice develop distinct macro- and microvascular complications;Mohan;Lab Invest,2008

5. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice;Zhao;J Am Soc Nephrol,2006

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update: the role of epigenetics in the metabolic memory of diabetic complications;American Journal of Physiology-Renal Physiology;2024-09-01

2. Histone deacetylases and inhibitors in diabetes mellitus and its complications;Biomedicine & Pharmacotherapy;2024-08

3. Role of histone deacetylase inhibitors in non-neoplastic diseases;Heliyon;2024-07

4. Mesenteric artery smooth muscle cells from hypertensive rats have increased microtubule acetylation;Biochemical Journal;2024-02-29

5. The potential of epigenetic compounds in treating diabetes;Epigenetics in Human Disease;2024